Richard C. Zoretic
Richard C. Zoretic's purchase track record
How the stock did after each of Richard C. Zoretic's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/11/2026 | MOH | $100K | +56.5% | +68.0% | +11.6% |
| 5/28/2025 | INNV | $173K | -2.2% | +22.5% | +15.7% |
| 5/16/2025 | INNV | $25K | -18.1% | +15.5% | +13.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
InnovAge Holding Corp. Earnings Report Due Next Week. InnovAge Holding Corp. is scheduled to release its next earnings report next week. Analysts surveyed by Wall Street are expecting the company to post earnings growth compared to the same period last year. Investors will be watching to see if actual results meet those expectations. The stock is currently trading near a support level of $8.09.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Aveanna Healthcare Featured in Healthcare Stock Roundup. Aveanna Healthcare Holdings was included in a recent article discussing top healthcare stocks, highlighting its role in the sector. Separately, a Yahoo Finance piece questioned if the company will beat earnings estimates again, while another article focused on Ensign Group's financial flexibility. These mentions place Aveanna in the conversation regarding healthcare sector performance and upcoming earnings expectations.
Transaction History
| MOH | ▲ Buy | Grant | 304 | $55K | 10/1/2026 | View on chart |
| INNV | ▲ Buy | Grant | 8,539 | $0 | 7/1/2026 | View on chart |
| MOH | ▲ Buy | Grant | 237 | $55K | 7/1/2026 | View on chart |
| MOH | ▲ Buy | Grant | 405 | $55K | 4/1/2026 | View on chart |
| MOH | ▲ Buy | Open Market | 800 | $100K | 2/11/2026 | View on chart |
| MOH | ▲ Buy | Grant | 317 | $55K | 1/1/2026 | View on chart |
| MOH | ▲ Buy | Grant | 285 | $55K | 10/1/2025 | View on chart |
| INNV | ▲ Buy | Grant | 25,316 | $0 | 7/1/2025 | View on chart |
| MOH | ▲ Buy | Grant | 180 | $55K | 7/1/2025 | View on chart |
| INNV | ▲ Buy | Open Market | 8,450 | $34K | 5/30/2025 | View on chart |
| INNV | ▲ Buy | Open Market | 14,265 | $58K | 5/29/2025 | View on chart |
| INNV | ▲ Buy | Open Market | 20,000 | $81K | 5/28/2025 | View on chart |
| INNV | ▲ Buy | Open Market | 1,198 | $5K | 5/23/2025 | View on chart |
| INNV | ▲ Buy | Open Market | 700 | $3K | 5/22/2025 | View on chart |
| INNV | ▲ Buy | Open Market | 1,147 | $5K | 5/21/2025 | View on chart |
| INNV | ▲ Buy | Open Market | 807 | $3K | 5/20/2025 | View on chart |
| INNV | ▲ Buy | Open Market | 2,086 | $9K | 5/16/2025 | View on chart |
| MOH | ▲ Buy | Grant | 168 | $55K | 4/1/2025 | View on chart |
| MOH | ▲ Buy | Grant | 189 | $55K | 1/1/2025 | View on chart |
| MOH | ▲ Buy | Grant | 161 | $55K | 10/1/2024 | View on chart |
| INNV | ▲ Buy | Grant | 19,841 | $0 | 9/5/2024 | View on chart |
| MOH | ▲ Buy | Grant | 188 | $55K | 7/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 136 | $55K | 4/1/2024 | View on chart |
| AVAH | ▲ Buy | Grant | 53,942 | $0 | 2/21/2024 | View on chart |
| AVAH | ▲ Buy | Option Exercise | 103,175 | — | 2/14/2024 | View on chart |
| MOH | ▲ Buy | Grant | 152 | $55K | 1/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 168 | $55K | 10/1/2023 | View on chart |
| AVAH | ▲ Buy | Option Exercise | 61,611 | — | 8/15/2023 | View on chart |
| MOH | ▲ Buy | Grant | 183 | $55K | 7/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 206 | $55K | 4/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 167 | $55K | 1/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 167 | $55K | 10/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 194 | $55K | 7/1/2022 | View on chart |
| AVAH | ▲ Buy | Option Exercise | 10,509 | — | 6/30/2022 | View on chart |
| MOH | ▲ Buy | Grant | 162 | $55K | 4/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 173 | $55K | 1/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 203 | $55K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Molina Healthcare Draws Value Investor Interest Amid Recent Pressure
Diamond Hill Capital has highlighted long-term value in Molina Healthcare following recent stock price pressure. This view is echoed by other market analyses questioning if the stock is a value play. The company is currently trading near its 52-week low, with an average analyst target of $209.12.
Molina Healthcare Draws Value Investor Interest Amid Recent Pressure. Diamond Hill Capital has highlighted long-term value in Molina Healthcare following recent stock price pressure. This view is echoed by other market analyses questioning if the stock is a value play. The company is currently trading near its 52-week low, with an average analyst target of $209.12.